These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1117043)
21. Role of CYP3A5 in abnormal clearance of methadone. De Fazio S; Gallelli L; De Siena A; De Sarro G; Scordo MG Ann Pharmacother; 2008 Jun; 42(6):893-7. PubMed ID: 18460585 [TBL] [Abstract][Full Text] [Related]
22. Relationship between methadone and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in urine samples from Norwegian prisons. Bernard JP; Opdal MS; Karinen R; Mørland J; Khiabani HZ Eur J Clin Pharmacol; 2007 Aug; 63(8):777-82. PubMed ID: 17576548 [TBL] [Abstract][Full Text] [Related]
23. Use of capillary electrophoresis and poly(ethylene oxide) as the coating agent for the determination of substances related to heroin addiction and treatment. Di Pietro N; Placanica G; Fiorini I; Manera C; Orlando C; Palombo F; Saccomanni G; Salotti V; Macchia M J Anal Toxicol; 2006; 30(9):679-82. PubMed ID: 17137528 [TBL] [Abstract][Full Text] [Related]
24. Biliary and urinary elimination of methadone and its metabolites in the rat. Baselt RC; Casarett LJ Biochem Pharmacol; 1972 Oct; 21(20):2704-12. PubMed ID: 4647078 [No Abstract] [Full Text] [Related]
25. Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS. Alburges ME; Huang W; Foltz RL; Moody DE J Anal Toxicol; 1996 Oct; 20(6):362-8. PubMed ID: 8889671 [TBL] [Abstract][Full Text] [Related]
26. Analysis of methadone and metabolites in biological fluids with gas chromatography--mass spectrometry. Kang GI; Abbott FS J Chromatogr; 1982 Sep; 231(2):311-9. PubMed ID: 7130311 [TBL] [Abstract][Full Text] [Related]
27. A method for the detection of drugs of abuse in urine. Wislocki A; Martel P; Ito R; Dunn WS; McGuire CD Health Lab Sci; 1974 Jan; 11(1):13-9. PubMed ID: 4808613 [No Abstract] [Full Text] [Related]
28. Porous silicon mass spectrometry as an alternative confirmatory assay for compliance testing of methadone. Guinan TM; Neldner D; Stockham P; Kobus H; Della Vedova CB; Voelcker NH Drug Test Anal; 2017 May; 9(5):769-777. PubMed ID: 27364015 [TBL] [Abstract][Full Text] [Related]
29. Comparison of GLC-EMIT analysis for the assay of methadone and its major metabolite in urine. Ferrara SD; Tedeschi L; Castagna F; Marigo M Forensic Sci; 1978; 11(3):181-8. PubMed ID: 680610 [TBL] [Abstract][Full Text] [Related]
30. Gas chromatographic detection of methadone and morphine in the urine of drug addicts. van der Slooten EP; van der Helm HJ; Geerlings PJ J Chromatogr; 1971 Aug; 60(1):131-3. PubMed ID: 5118819 [No Abstract] [Full Text] [Related]
31. Methadone conversion to EDDP during GC-MS analysis of urine samples. Galloway FR; Bellet NF J Anal Toxicol; 1999; 23(7):615-9. PubMed ID: 10595849 [TBL] [Abstract][Full Text] [Related]
32. Review of LC techniques for determination of methadone and its metabolite in the biological samples. Shan X; Zhang L; Yang B Prep Biochem Biotechnol; 2021; 51(10):953-960. PubMed ID: 34365899 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat. Gerardy BM; Kapusta D; Dumont P; Poupaert JH Drug Metab Dispos; 1986; 14(4):477-81. PubMed ID: 2873996 [TBL] [Abstract][Full Text] [Related]
34. Quantification of methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine in third instar larvae of Lucilia sericata (Diptera: Calliphoridae) using liquid chromatography-tandem mass spectrometry. Gosselin M; Ramirez Fernandez Mdel M; Wille SM; Samyn N; De Boeck G; Bourel B J Anal Toxicol; 2010 Sep; 34(7):374-80. PubMed ID: 20822674 [TBL] [Abstract][Full Text] [Related]
35. Screening for the major methadone metabolite and methamphetamine in urine. Gupta RN; Chittim BG; Keane PM J Chromatogr Sci; 1974 Feb; 12(2):67-70. PubMed ID: 4815974 [No Abstract] [Full Text] [Related]
36. Testing for Drugs in Exhaled Breath Collected With ExaBreath in a Drug Dependence Population: Comparison With Data Obtained in Urine After Liquid Chromatographic-Tandem Mass Spectrometric Analyses. Kintz P; Mathiaux F; Villéger P; Gaulier JM Ther Drug Monit; 2016 Feb; 38(1):135-9. PubMed ID: 26222873 [TBL] [Abstract][Full Text] [Related]
37. Compliance with methadone-based substitutive treatment: a proposed model based on immunoassay urinary sample screening. Bézie Y; Talon V; Lillo A; Illier C; Billaud E; Prognon P; Boutouyrie P Ther Drug Monit; 2004 Jun; 26(3):271-6. PubMed ID: 15167627 [TBL] [Abstract][Full Text] [Related]
38. An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes. Moody DE; Lin SN; Chang Y; Lamm L; Greenwald MK; Ahmed MS J Anal Toxicol; 2008 Apr; 32(3):208-19. PubMed ID: 18397572 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous detection of a wide variety of commonly abused drugs in a urine screening program using thin-layer identification techniques. Kaistha KK; Tadrus R; Janda R J Chromatogr; 1975 Apr; 107(2):359-79. PubMed ID: 1137995 [TBL] [Abstract][Full Text] [Related]
40. Evaluating the relationship of methadone concentrations and EDDP formation in chronic pain patients. Leimanis E; Best BM; Atayee RS; Pesce AJ J Anal Toxicol; 2012 May; 36(4):239-49. PubMed ID: 22511698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]